Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance
(1) Background: Pulsed electric field (PEF) techniques are commonly used to support the delivery of various molecules. A PEF seems a promising method for low permeability drugs or when cells demonstrate therapy resistance and the cell membrane becomes an impermeable barrier. (2) Methods: In this stu...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-03-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/27/7/2052 |
| _version_ | 1797438476610699264 |
|---|---|
| author | Nina Rembiałkowska Vitalij Novickij Dagmara Baczyńska Magda Dubińska-Magiera Jolanta Saczko Julia Rudno-Rudzińska Magdalena Maciejewska Julita Kulbacka |
| author_facet | Nina Rembiałkowska Vitalij Novickij Dagmara Baczyńska Magda Dubińska-Magiera Jolanta Saczko Julia Rudno-Rudzińska Magdalena Maciejewska Julita Kulbacka |
| author_sort | Nina Rembiałkowska |
| collection | DOAJ |
| description | (1) Background: Pulsed electric field (PEF) techniques are commonly used to support the delivery of various molecules. A PEF seems a promising method for low permeability drugs or when cells demonstrate therapy resistance and the cell membrane becomes an impermeable barrier. (2) Methods: In this study, we have used doxorubicin-resistant and sensitive models of human breast cancer (MCF-7/DX, MCF-7/WT) and colon cancer cells (LoVo, LoVoDX). The study aimed to investigate the susceptibility of the cells to doxorubicin (DOX) and electric fields in the 20–900 ns pulse duration range. The viability assay was utilized to evaluate the PEF protocols’ efficacy. Cell confluency and reduced glutathione were measured after PEF protocols. (3) Results: The obtained results showed that PEFs significantly supported doxorubicin delivery and cytotoxicity after 48 and 72 h. The 60 kV/cm ultrashort pulses × 20 ns × 400 had the most significant cytotoxic anticancer effect. The increase in DOX concentration provokes a decrease in cell viability, affected cell confluency, and reduced GSSH when combined with the ESOPE (European Standard Operating Procedures of Electrochemotherapy) protocol. Additionally, reactive oxygen species after PEF and PEF-DOX were detected. (4) Conclusions: Ultrashort electric pulses with low DOX content or ESOPE with higher DOX content seem the most promising in colon and breast cancer treatment. |
| first_indexed | 2024-03-09T11:38:29Z |
| format | Article |
| id | doaj.art-b1a1f0ce7be949a88da43d04ca6b2173 |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-03-09T11:38:29Z |
| publishDate | 2022-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-b1a1f0ce7be949a88da43d04ca6b21732023-11-30T23:38:54ZengMDPI AGMolecules1420-30492022-03-01277205210.3390/molecules27072052Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug ResistanceNina Rembiałkowska0Vitalij Novickij1Dagmara Baczyńska2Magda Dubińska-Magiera3Jolanta Saczko4Julia Rudno-Rudzińska5Magdalena Maciejewska6Julita Kulbacka7Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, PolandInstitute of High Magnetic Fields, Vilnius Gediminas Technical University, LT-03227 Vilnius, LithuaniaDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, PolandDepartment of Animal Developmental Biology, Faculty of Biological Science, University of Wroclaw, Sienkiewicza 21, 50-335 Wroclaw, PolandDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, PolandDepartment of General and Oncological Surgery, Medical University Hospital, Borowska 211, 50-556 Wroclaw, PolandLaboratory of Experimental Anticancer Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Rudolfa Weigla 12, 53-114 Wroclaw, PolandDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland(1) Background: Pulsed electric field (PEF) techniques are commonly used to support the delivery of various molecules. A PEF seems a promising method for low permeability drugs or when cells demonstrate therapy resistance and the cell membrane becomes an impermeable barrier. (2) Methods: In this study, we have used doxorubicin-resistant and sensitive models of human breast cancer (MCF-7/DX, MCF-7/WT) and colon cancer cells (LoVo, LoVoDX). The study aimed to investigate the susceptibility of the cells to doxorubicin (DOX) and electric fields in the 20–900 ns pulse duration range. The viability assay was utilized to evaluate the PEF protocols’ efficacy. Cell confluency and reduced glutathione were measured after PEF protocols. (3) Results: The obtained results showed that PEFs significantly supported doxorubicin delivery and cytotoxicity after 48 and 72 h. The 60 kV/cm ultrashort pulses × 20 ns × 400 had the most significant cytotoxic anticancer effect. The increase in DOX concentration provokes a decrease in cell viability, affected cell confluency, and reduced GSSH when combined with the ESOPE (European Standard Operating Procedures of Electrochemotherapy) protocol. Additionally, reactive oxygen species after PEF and PEF-DOX were detected. (4) Conclusions: Ultrashort electric pulses with low DOX content or ESOPE with higher DOX content seem the most promising in colon and breast cancer treatment.https://www.mdpi.com/1420-3049/27/7/2052drug resistancehuman adenocarcinomadoxorubicinelectroporationdrug delivery |
| spellingShingle | Nina Rembiałkowska Vitalij Novickij Dagmara Baczyńska Magda Dubińska-Magiera Jolanta Saczko Julia Rudno-Rudzińska Magdalena Maciejewska Julita Kulbacka Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance Molecules drug resistance human adenocarcinoma doxorubicin electroporation drug delivery |
| title | Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance |
| title_full | Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance |
| title_fullStr | Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance |
| title_full_unstemmed | Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance |
| title_short | Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance |
| title_sort | micro and nanosecond pulses used in doxorubicin electrochemotherapy in human breast and colon cancer cells with drug resistance |
| topic | drug resistance human adenocarcinoma doxorubicin electroporation drug delivery |
| url | https://www.mdpi.com/1420-3049/27/7/2052 |
| work_keys_str_mv | AT ninarembiałkowska microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance AT vitalijnovickij microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance AT dagmarabaczynska microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance AT magdadubinskamagiera microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance AT jolantasaczko microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance AT juliarudnorudzinska microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance AT magdalenamaciejewska microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance AT julitakulbacka microandnanosecondpulsesusedindoxorubicinelectrochemotherapyinhumanbreastandcoloncancercellswithdrugresistance |